当前位置:首页 - 行情中心 - 南模生物(688265) - 财务分析 - 现金流量表

南模生物

(688265)

  

流通市值:35.87亿  总市值:35.87亿
流通股本:7796.35万   总股本:7796.35万

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金273,931,584.88166,615,684.1466,344,553.51379,544,474.49
  收到的税费返还---3,653,434.59
  收到其他与经营活动有关的现金9,099,991.977,040,017.741,720,549.4920,635,284.06
  经营活动现金流入小计283,031,576.85173,655,701.8868,065,103403,833,193.14
  购买商品、接受劳务支付的现金68,810,042.4544,881,767.9224,776,535.6293,241,115.13
  支付给职工以及为职工支付的现金143,887,427.696,730,926.4252,021,158.83165,469,638.48
  支付的各项税费2,626,197.931,997,337.421,392,607.669,290,764.15
  支付其他与经营活动有关的现金48,066,825.9126,373,066.5416,621,294.2464,267,655.9
  经营活动现金流出小计263,390,493.89169,983,098.394,811,596.35332,269,173.66
  经营活动产生的现金流量净额19,641,082.963,672,603.58-26,746,493.3571,564,019.48
二、投资活动产生的现金流量:
  收回投资收到的现金2,351,180,132.491,511,920,549.41691,772,149.162,488,745,298.68
  取得投资收益收到的现金45,827.7245,827.72104,414.02-
  处置固定资产、无形资产和其他长期资产收回的现金净额23,416.551,951.33-137,027.9
  投资活动现金流入小计2,351,249,376.761,511,968,328.46691,876,563.182,488,882,326.58
  购建固定资产、无形资产和其他长期资产支付的现金19,621,909.647,553,546.993,871,150.3325,237,036.02
  投资支付的现金2,413,100,0001,517,000,000777,000,0002,354,010,000
  投资活动现金流出小计2,432,721,909.641,524,553,546.99780,871,150.332,379,247,036.02
  投资活动产生的现金流量净额-81,472,532.88-12,585,218.53-88,994,587.15109,635,290.56
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金---10,004,068.89
  支付其他与筹资活动有关的现金14,702,993.058,796,267.423,702,170.5673,098,791.33
  筹资活动现金流出小计14,702,993.058,796,267.423,702,170.5683,102,860.22
  筹资活动产生的现金流量净额-14,702,993.05-8,796,267.42-3,702,170.56-83,102,860.22
四、汇率变动对现金及现金等价物的影响-672,617.2-225,891.22-62,777.96515,474.38
  现金及现金等价物净增加额平衡项目0-0.0100
五、现金及现金等价物净增加额-77,207,060.17-17,934,773.6-119,506,029.0298,611,924.2
  加:期初现金及现金等价物余额196,214,845.6196,214,845.6196,214,845.697,602,921.4
  期末现金及现金等价物余额119,007,785.43178,280,07276,708,816.58196,214,845.6
补充资料:
  净利润-18,167,375-6,495,504.05
  资产减值准备-1,712,063.32-844,076.86
  固定资产和投资性房地产折旧-15,143,675.14-29,685,141.95
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-15,143,675.14-29,685,141.95
  无形资产摊销-3,726,238.9-6,801,627.64
  长期待摊费用摊销-8,972,725.81-17,962,341.57
  处置固定资产、无形资产和其他长期资产的损失----20,207.24
  固定资产报废损失-44,107.19-55,081.16
  公允价值变动损失--8,610,993.1--19,301,458.69
  财务费用-1,566,515.03-3,626,896.54
  投资损失--1,181,013.5--1,041,919.05
  递延所得税--589,887.75--3,759,022.98
  其中:递延所得税资产减少--187,544.54--4,835,970.62
    递延所得税负债增加--402,343.21-1,076,947.64
  存货的减少--4,462,148.24-2,314,280.98
  经营性应收项目的减少--22,590,807.28--8,364,848.45
  经营性应付项目的增加--17,727,776.83-6,048,267.53
  其他--8,111,810.24-2,361,382.9
  现金的期末余额-178,280,072-196,214,845.6
  减:现金的期初余额-196,214,845.6-97,602,921.4
  现金及现金等价物的净增加额--17,934,773.6-98,611,924.2
公告日期2025-10-302025-08-292025-04-292025-04-29
审计意见(境内)标准无保留意见
TOP↑